Keyword: Allergan

News

Mylan Said to Prepare Poison Pill Potion Against Teva

24.04.2015 - US-managed generics drugmaker Mylan, now domiciled in the Netherlands, is said to be preparing a "poison pill" defense to escape its pursuit by Israeli generics giant Teva. Teva...

News

Endo International Tries to Spoil Valeant’s Salix Deal

16.03.2015 - Dublin, Ireland-based Endo International has made a takeover bid for US drugmaker Salix Pharmaceuticals in an effort to thwart Valeant Pharmaceuticals International's $10 billion...

News

DuPont Rejects Activist Investor’s Universal Ballot Request

05.03.2015 - DuPont has rejected a request from activist investor Nelson Peltz and his hedge fund Trian to use a universal ballot in an upcoming vote on candidates for the chemical producer's...

News

Activist hedge funds' Assets Swell Six-fold in ten Years

25.02.2015 - With activist investors continuing to make headlines in the chemical industry, especially in the US, the struggles of Dow, DuPont and Botox producer Allergan are cases in point -...

News

Valeant Slashes Stake in Allergan After Losing Bid

24.11.2014 - Valeant Pharmaceuticals International has cut its stake in US drugmaker Allergan to 0.1%, making the sale three days after Actavis trumped its offer for the Botox maker.In a...

News

Allergan Agrees to be Bought by Actavis

19.11.2014 - After a seven month-long power struggle, US Botox manufacturer Allergan has agreed to be bought by Ireland-based drugmaker Actavis for $66 billion or $219 per share. This is more...

News

Allergan Said to Have Received Bid from Actavis

04.11.2014 - Botox maker Allergan, which is fighting a hostile takeover bid by Valeant Pharmaceutical, is said to have been approached about a potential transaction by another party. The news...

News

Allergan Special Shareholder Meeting Set for December

17.09.2014 - US drugmaker Allergan, which makes the Botox anti-wrinkle treatment, said it has reached agreement with suitors Pershing Square Capital Management and Canada's Valeant...